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University of California, San Francisco pull-down experiments with the same extracts. Few pro-
teins (10) were eluted from the GST column, and theseSan Francisco, California 94107
2 Section for Developmental Biology were excluded from analysis.
Twenty “EB1-specific” proteins were identified overDepartment of Cell and Molecular Biology
Lund University the course of five independent pull-down experiments.
However, of these, only six candidates were identifiedBMC B13
22184 Lund in all five trials: CLIP190 (Mr [relative molecular weight]
190 kDa; the Drosophila ortholog of vertebrate CLIP-Sweden
170, which localizes to the plus ends of microtubules),
Orbit/MAST (Mr  165 kDa; a microtubule plus-end-
associated protein that interacts with CLIP-170), non-Summary
muscle myosin II heavy chain (Mr 230 kDa), the minus-
end-directed kinesin, Ncd (Mr  75 kDa), ShortstopMembers of the Rho/Rac/Cdc42 superfamily of
(Mr  590 kDa; a member of the spectraplakin family ofGTPases [1,2] and their upstream activators, guanine
actin/microtubule cross-linking proteins), and DRho-nucleotide exchange factors (GEFs) [3], have emerged
GEF2 (Mr  280 kDa; a member of the Dbl family ofas key regulators of actin and microtubule dynamics.
Rho GEFs). In this paper, we focused on DRhoGEF2In their GTP bound form, these proteins interact with
for further study; analyses of the other candidate EB1downstream effector molecules that alter actin and
binding factors will be described elsewhere.microtubule behavior. During Drosophila embryogen-
The association of DRhoGEF2 with EB1 in vitro raisedesis, a G subunit (Concertina) and a Rho-type gua-
the possibility that this protein may localize to the tips ofnine nucleotide exchange factor (DRhoGEF2) have
microtubules. To test this idea, we generated polyclonalbeen implicated in the dramatic epithelial-cell shape
antibodies against the C-terminal 720 amino acid resi-changes that occur during gastrulation [4–6] and mor-
dues of DRhoGEF2. These antibodies recognized aphogenesis [7]. Using Drosophila S2 cells as a model
280 kDa polypeptide on immunoblots of S2 cell ex-system, we show that DRhoGEF2 induces contractile
tracts; this polypeptide was eliminated after DRhoGEF2cell shape changes by stimulating myosin II via the
RNAi treatment, indicating that the antibodies were re-Rho1 pathway. Unexpectedly, we found that DRho-
acting with the correct polypeptide (Figure S1B).GEF2 travels to the cell cortex on the tips of growing
By immunofluorescence, anti-DRhoGEF2 antibodiesmicrotubules by interaction with the microtubule plus-
recognized punctate structures distributed throughoutend tracking protein EB1. The upstream activator Con-
the cell (Figure 1A). Superimposed upon this punctatecertina, in its GTP but not GDP bound form, dissociates
pattern, however, were short (1 m) linear tracks thatDRhoGEF2 from microtubule tips and also causes cel-
colocalized with the tips of microtubules. Moreover, im-lular contraction. We propose that DRhoGEF2 uses
munofluorescent staining of DRhoGEF2 in S2 cells ex-microtubule dynamics to search for cortical subdo-
pressing low amounts of EB1-EGFP indicated that thesemains of receptor-mediated G activation, which in turn
two proteins colocalize exactly at microtubule tips (Fig-causes localized actomyosin contraction associated
ure S2). In the perinuclear region of many cells, DRho-with morphogenetic movements during development.
GEF2 antibodies also stained larger spots that costained
with -tubulin, a centrosome marker (Figure S3). Deple-
Results and Discussion tion of DRhoGEF2 with RNAi eliminated antibody stain-
ing of all of these structures in S2 cells (data not shown).
Previously, we characterized the cellular functions of Thus, our immunofluorescence experiments reveal that
the microtubule plus-end binding protein EB1 in Dro- DRhoGEF2 exists in three pools within S2 cells: punctate
sophila S2 cells and showed that this protein plays an throughout the cell, at microtubule tips, and on centro-
important role in regulating microtubule dynamics and somes.
in the assembly and dynamics of the mitotic spindle [8]. We next tagged DRhoGEF2 with green fluorescent
In order to learn more about EB1’s functions, we sought protein (GFP) to examine its dynamic behavior through
to identify EB1 binding partners with affinity purification. time-lapse imaging with a spinning-disk microscope. As
We used recombinant Drosophila GST-EB1 bound to predicted from our immunofluorescence data, “comet-
glutathione Sepharose beads as an affinity chromatog- like” structures of DRhoGEF2-GFP moved from the cell
raphy matrix to bind interacting partners from S2 cell center toward the periphery in a manner that was very
extracts. Bound proteins were eluted from the beads similar to that observed for EB1-GFP (Movies 1 and 2).
In many cells, an intense spot of DRhoGEF2-GFP was
observed near the perinuclear region. This spot likely*Correspondence: vale@cmp.ucsf.edu
Current Biology
1828
Figure 1. DRhoGEF2 Localizes to Microtu-
bule Tips in an EB1-Dependent Manner
(A) Immunofluorescent localization of DRho-
GEF2 (blue) and tubulin (red) in an S2 cell
spread upon concanavalin A. DRhoGEF2
antibodies stain punctate cytoplasmic struc-
tures and also recognize the tips of microtu-
bules. Boxed regions indicate regions pre-
sented at higher magnification below.
(B) Immunofluorescent localization of DRho-
GEF2 (blue) and tubulin (red) in a cell depleted
of EB1 by a 7 day treatment with dsRNA.
DRhoGEF2 is no longer observed at microtu-
bule plus ends. Lower panels show boxed
regions at higher magnification. The scale bar
represents 5 m.
corresponded to the centrosome staining because the itive regulator of Rho1 [5–7]. To test whether Rho activa-
tion is involved in generating the unusual phenotypetips of nucleated microtubules emanated from this point
in a radial pattern. Microtubule dynamics are essential associated with DRhoGEF2 overexpression, we trans-
fected cells with constitutively active Rho1V14 and iden-for this movement because it could be eliminated with
either 10 M colchicine (data not shown) or 10 M taxol tified transfected cells with an antibody raised against
Drosophila Rho1. As predicted, most of the Rho1V14-(Movie 3). Thus, we conclude that DRhoGEF2 associates
with the tips of growing microtubules and exhibits plus- expressing cells (95%, n 293) duplicated the morphol-
ogy produced by DRhoGEF2 overexpression (Figureend tracking that is qualitatively similar to that described
for EB1. 2E). In order to next test if inhibition of Rho1 prevented
DRhoGEF2-induced shape change, we transfectedBecause DRhoGEF2 was isolated based upon its as-
sociation, direct or indirect, with EB1, we next depleted DRhoGEF2-EGFP into cells that had been treated with
Rho RNAi. Depletion of Rho1 by RNAi produced largeEB1 from cells with RNAi and examined whether the
association of DRhoGEF2 with microtubule tips was per- multinucleate cells that did not contract in response to
DRhoGEF2 overexpression (99% of cells, n  284) (Fig-turbed. In cultures treated with control dsRNA, scoring
of fixed cells stained for DRhoGEF2 and microtubules ure 2F). In contrast, RNAi inhibition of the other six Rho
family members did not block DRhoGEF2-induced con-revealed that 94% of the cells (n  300) had DRhoGEF2
associated with the microtubule tip. In contrast, in S2 traction (data not shown).
Active Rho is known to stimulate nonmuscle myosincells treated for 7 days with EB1 dsRNA, only 5% of the
cells (n  300) retained DRhoGEF2 at the plus ends II, and Halsell et al. demonstrated a genetic interaction
between DRhoGEF2 and myosin II during Drosophila(Figure 1B). These results demonstrate that targeting of
DRhoGEF2 to growing microtubule plus ends is an EB1- morphogenesis [7]. One well-characterized mechanism
by which Rho1 activates myosin II is Rho kinase (DROKdependent process.
To further understand DRhoGEF2 functions, we ex- in Drosophila) stimulation, which activates the motor by
phosphorylating the myosin light chain and by inactivat-amined how overexpression and depletion of the protein
affects the morphology of S2 cells. When S2 cells are ing myosin light chain phosphatase [9, 10]. In order to
determine if DROK is indeed downstream of DRhoGEF2,plated on concanavalin A, they adopt a “fried-egg” ap-
pearance with a dome-like central domain defined by we depleted DROK with RNAi or inhibited kinase activity
with Y-27632, a pharmacological inhibitor, and then ex-the nucleus and perinuclear organelle-rich region and
an extended, symmetrical lamella (Figures 2A and 2B; amined cell morphology after DRhoGEF2 overexpres-
sion. Both treatments significantly reduced the numbersMovie 4). In contrast, we found that overexpressing
DRhoGEF2 caused many cells (95%, n  366) to adopt of cells exhibiting the contracted morphology (DROK
RNAi to 7% [n  363] and Y-27632 to 7% [n  343];a smaller, contracted footprint on the substrate and to
become significantly taller than control cells. These ov- Figure 2G). From these data, we conclude that DRho-
GEF2 changes S2 cell morphology through Rho1 anderexpressing cells formed a skirt of abnormally large
membrane ruffles that tapered to the base of a raised, its downstream effector, DROK.
To confirm that myosin II is a downstream effector inorganelle-rich compartment, and the overall morphol-
ogy resembled a “bonnet” shape (Figures 2C and 2D; the DRhoGEF2 pathway in our system, we compared
the behavior of GFP-tagged myosin II in control S2 cellsMovie 5). This result suggested that DRhoGEF2 could
induce contractility, in agreement with the genetic phe- on concanavalin A with that of S2 cells overexpressing
DRhoGEF2. To perform this analysis, we generated anotype of DRhoGEF2 mutations. DRhoGEF2 depletion
by RNAi did not affect the morphology of S2 cells on stable cell line expressing the myosin II regulatory light
chain (RLC), known by Drosophila nomenclature as spa-con A surfaces (not shown); however, this morphology
is the result of lamella extension and not retraction. ghetti squash, under the control of the gene’s endoge-
nous promoter. Ectopic expression of RLC-GFP did notSeveral genetic studies implicate DRhoGEF2 as a pos-
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Upon overexpression of DRhoGEF2, punctae of RLC-
GFP were rarely observed. Instead, the majority of RLC-
GFP signal was present in circular “purse string” struc-
tures surrounding the organelle-dense region at the
center of the cell (Figure 3B). Time-lapse observation
revealed that peripheral formation of RLC-GFP punctae
and retrograde flow were infrequent in DRhoGEF2-over-
expressing cells (Movie 7) and that these RLC-GFP-
containing purse strings were stable over a span of
hours. The location and concentration of the myosin II
suggests that actomyosin contraction is responsible for
producing the bonnet-shaped appearance of these
cells. From these observations, we propose that DRho-
GEF2 regulates myosin II dynamics and contractility in
S2 cells.
Genetic analyses of epithelial-sheet invagination in
the early Drosophila embryo suggest that DRhoGEF2
may act downstream of the heterotrimeric G protein
Concertina (Cta) [4]. To examine directly whether Con-
certina can activate DRhoGEF2, we transfected cells
either with Myc-tagged wild-type Cta or Myc-tagged
Cta bearing a constitutively activating point mutation
(R277H) that inactivates GTPase activity [14], and we
examined the morphology of the transfected cells. Cells
expressing Myc-Cta were morphologically indistin-
guishable from untransfected cells (Figure 3C), and only
3% of cells displayed a mildly contracted phenotype
(n  392). In contrast, the majority of cells (90%, n 
371) expressing Myc-CtaR277H exhibited the contracted
Figure 2. DRhoGEF2-Mediated Cellular Shape Changes Require morphology and myosin II purse string reminiscent ofRho1
DRhoGEF2 overexpression (Figure 3D). Similar results
(A and B) Three-dimensional reconstructions of a control S2 cell
were obtained with three other constitutively activatedstained with rhodamine-phalloidin and spread on concanavalin A in
Concertina constructs (data not shown). However, thethe x-y (A) and x-z (B) planes reveal that the cells adopt a discoid
shape change was prevented in 88% of these cells (n shape. Nuclei and organelles reside in the center dome-like region
and membrane ruffles are present in the peripheral lamella. 270) if they were pretreated for 7 days with dsRNA so
(C and D) In contrast, x-y (C) and x-z (D) projections of a cell overex- that DRhoGEF2 was depleted (Figure 3E). These results
pressing DRhoGEF2 and identified with our antibodies to the protein suggest that Concertina can act upstream of DRhoGEF2
show a dramatic change in cell shape. These cells have a smaller
to regulate S2 cell morphology.footprint on the coverslip, produce massive membrane ruffles that
We next wished to determine whether activation ofskirt the cell, and push their organelle-rich central cytoplasm axially
DRhoGEF2 through Concertina affected its associationaway from the coverslip.
(E) S2 cells overexpressing constitutively active Rho1V14 and identi- with the microtubule cytoskeleton. Cells expressing
fied by immunofluorescence with an antibody against Rho1 adopt Myc-Cta or Myc-CtaR277H were fixed and double stained
a contracted morphology indistinguishable from that of cells overex- for the Myc epitope tag and for DRhoGEF2. Overexpres-
pressing DRhoGEF2.
sion of wild-type Concertina did not affect DRhoGEF2(F) Depletion of Rho1 from S2 cells with RNAi produces large multi-
association with microtubule plus ends or with the cen-nucleate cells that do not adopt the contracted morphology upon
trosome (88% of cells, n  125; Figure 4A). However,overexpression of DRhoGEF2-GFP.
(G) Treatment with the Rho kinase inhibitor Y-27632 also prevents constitutively activated Concertina resulted in DRho-
shape changes induced by DRhoGEF2-GFP. The scale bar repre- GEF2 dissociation from microtubule tips; only 10% (n 
sents 5 m. 128) of the cells showed any colocalization of DRho-
GEF2 with microtubule plus ends (Figure 4B). Instead,
produce observable defects in actin organization or be- DRhoGEF2 exhibited a diffuse staining pattern through-
havior (data not shown and [11]); its distribution exactly out the cell; this pattern likely represents association
coincided with the myosin II distribution determined by with the plasma membrane. Targeting of EB1 to the plus
immunofluorescence staining of the same cells (data not ends was not perturbed by CtaR277H (99%, n 350; Figure
shown). RLC-GFP typically incorporated into punctae in S4), suggesting that Concertina signaling regulates the
the cell periphery and into higher-order structures in interactions between DRhoGEF2 and factors at microtu-
the central region of the cells (Figure 3A). Time-lapse bule tips.
spinning-disk confocal microscopy revealed that punc-
tae of RLC-GFP formed in the distal cell periphery and
then translocated centripetally at a constant rate of 4.0 Conclusions
In our attempt to identify novel cellular factors that inter-0.3m/min toward the cell center (Movie 6). Such behav-
ior of RLC-GFP is qualitatively very similar to the behav- act with EB1, we unexpectedly discovered that DRho-
GEF2, a key regulator of morphogenesis in Drosophila,ior of fluorescently labeled myosin II in cultured mamma-
lian cells [12, 13]. associates with the tips of growing microtubules. This
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Figure 3. DRhoGEF2 Regulates the Behavior
of Nonmuscle Myosin II
(A) An untransfected control S2 cell on conca-
navalin A. The cell expresses RLC-GFP (blue)
and is stained with antibodies to DRhoGEF2
(red). RLC-GFP is present in punctate spots
in the cell periphery and circumferential bun-
dles in the cell interior. Note: The fixation
technique required to preserve RLC-GFP
does not preserve microtubule-tip-associ-
ated structures.
(B) An S2 cell both expressing RLC-GFP
(blue) and overexpressing DRhoGEF2 (red)
and identified by immunofluorescence for the
latter. In this cell, RLC-GFP is found predomi-
nantly in a circular “purse string” structure
surrounding the organelle-rich domain. The
scale bar represents 5 m.
(C–E) Expression of constitutively active Con-
certina induces cellular contraction in a
DRhoGEF2-dependent manner. A cell line ex-
pressing RLC-GFP was transfected with
Myc-tagged versions of Concertina and iden-
tified with an antibody to the epitope tag (not
shown). The cell margin is indicated with the
yellow lines. (C) Overexpression of wild-type
Concertina (Cta) does not affect cell morphol-
ogy or myosin distribution. (D) However, over-
expression of constitutively active Myc-Con-
certina (CtaR277H) causes S2 cells to contract
and form a myosin II purse string indistinguishable from transfection with DRhoGEF2 or Rho1V14. (E) Depletion of DRhoGEF2 with RNAi
prevents cellular contraction or myosin II redistribution elicited by constitutively active Concertina. The scale bar represents 5 m.
interesting type of intracellular motility required EB1 in widely employed module for bundling and contraction of
actin filaments; it is involved in the formation of adhesiona manner analogous to the EB1-dependent microtubule
plus-end tracking of the vertebrate adenomatous poly- structures and stress fibers, retraction of the trailing
edge in migrating cells, muscular contraction, morpho-posis coli (APC) tumor suppressor protein [15]. To our
knowledge, this finding represents the first example of genetic cell shape changes, and construction of the
cleavage furrow at the end of mitosis [9]. Context- anda regulator of the actin cytoskeleton that tracks along
microtubule plus ends. Moreover, the dissociation of location-specific activation of the Rho1/Rho kinase/
myosin II module is likely to reside in the activation ofDRhoGEF2 from microtubule tips upon activation of
Concertina also represents the first example of a reg- specific RhoGEFs, over 20 of which reside within the
Drosophila genome [16]. This hypothesis is consistentulated association of a protein with the microtubule
plus end. with observations that inhibition of Rho1 or its down-
stream effectors causes a dramatic cytokinesis failureOur dissection of the DRhoGEF2 pathway at a cellular
level is also consistent with genetic studies of Drosoph- in S2 cells and embryos [17–19], but inhibition of DRho-
GEF2 does not ([5] and [6]; S.R. and R.V., unpublishedila morphogenesis. These studies implicate Concertina
in myosin II contractility through the Rho/Rho kinase data). Instead, DRhoGEF2 has only been implicated in
morphogenetic cell shape changes in epithelial cells.pathway. The Rho1/Rho kinase/myosin II system is a
Figure 4. Activation of DRhoGEF2 by Con-
certina Correlates with Its Dissociation from
the Microtubule Tip
S2 cells were transfected with wild-type Myc-
Concertina (Cta) or constitutively active Myc-
Concertina (Myc-CtaR277H). Cells were then
stained with antibodies against DRhoGEF2
and transfectants were identified with anti-
bodies to the epitope tag (not shown).
(A) DRhoGEF2 association with microtubule
plus ends is unaffected by expression of wild-
type Myc-Cta.
(B) However, upon expression of Myc-
CtaR277H, DRhoGEF2 immunofluorescence no
longer exhibits an interaction with microtu-
bule tips and is instead associated with the
plasma membrane. The scale bar represents
5 m.
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Figure 5. A Speculative Model for the Role
of Microtubule Dynamics during DRhoGEF2-
Mediated Cellular Shape Change
See text for details.
Thus, we believe that the signaling pathway that we have of the protein required either to respond to upstream
inputs or to locally activate Rho1 in a cortical subdo-engineered in S2 cells recapitulates events involved in
the cellular shape changes preceding gastrulation in main. This idea is supported by our observation that,
at very low expression levels and without ConcertinaDrosophila blastula epithelia cells [20, 21].
However, in Drosophila development, this signaling signaling, DRhoGEF2-GFP efficiently tracks microtubule
ends without activating cellular contraction. Alterna-pathway must be activated in a polarized manner by an
unidentified receptor and its ligand (possibly the protein tively, it is possible that interaction with EB1 or some
other protein at the microtubule plus end primes DRho-encoded by the folded gastrulation gene [22]) so that
myosin contraction occurs locally at the apical surface. GEF2 for activation at the cortex. A third possibility is
that microtubule dynamic instability is not uniform withinIn such a setting of asymmetric signaling, we propose
that the intracellular transport of DRhoGEF2 on microtu- a polarized cell but is locally modulated in order to de-
liver DRhoGEF2 to the cortex in a nonrandom manner.bule plus ends may play an important role in localized
activation of the pathway. We speculate that inactive Testing between these hypotheses will require identifi-
cation of the signaling components (i.e., the ligand-DRhoGEF2 interacts with the tips of microtubules,
whereupon these growing microtubules deliver “pack- receptor pair) that act upstream of Concertina, reconsti-
tution of the complete pathway in S2 cells, and theets” of DRhoGEF2 in the vicinity of the actin cortex
(Figure 5). If DRhoGEF2 does not receive an activating selective disruption of the association of DRhoGEF2
with microtubule tips in Drosophila embryos.input, it diffuses back into the cytoplasm to begin the
transport cycle anew. However, if DRhoGEF2 is deliv-
ered to a subcortical region containing a high concentra- Experimental Procedures
tion of receptor-activated Concertina, DRhoGEF2 can
Molecular Biologylocally activate the Rho1/Rho kinase/myosin II module.
DRhoGEF2-EGFP was constructed in three steps. First, making useMoreover, because DRhoGEF2 possesses potential
of a unique EcoRi site (at bp 3129) and engineering a 5 KpnI site
lipid (pleckstrin homology) and protein-protein (PDZ, to the first fragment and an XbaI site at the 3 end of the second,
RGS, and DH [Dbl homology]) interaction domains, mi- we used PCR to amplify two fragments of the DRhoGEF2 cDNA.
The EGFP coding sequence was also amplified with PCR from thecrotubule-delivered DRhoGEF2 may be retained at the
EGFP-C1 vector (Clontech, Palo Alto, CA), and the pieces werecortex if activated by Concertina. Although we propose
successively cloned into the pMT-V5-his A vector (Invitrogen, Carls-a microtubule-assisted activation of the Rho pathway
bad, CA). The Concertina expression constructs were made by PCRduring cellular shape changes during morphogenesis
with primers containing sequence for the Myc epitope tag and 5
(such as in epithelial cells), similar models that account EcoRI and 3 NotI restriction sites, and then by cloning into the
for small GTPase activation during cellular motility have pMT/V5-His A vector (Concertina and ConcertinaR277H cDNAs were
the gift of Eric Wieschaus, Princeton University). The GAL4 expres-been suggested as well [23, 24].
sion plasmid was constructed similarly with yeast genomic DNA asIn principle, interactions between DRhoGEF2 and its
a starting template. pMT-EB1-GFP was constructed by PCR-SOEcortical activators could occur through diffusion within
(splicing by overlap extension) with a cDNA encoding Drosophilathe cytoplasm. The evolution of this elaborate microtu-
EB1 and EGFP-C1 as templates.
bule polymerization-based transport mechanism un-
doubtedly reflects some important property of the sig-
Cell Culture and RNA Interference
naling pathway that we do not yet understand. Perhaps Drosophila Schneider S2 cells were cultured and RNAi was per-
the amount of DRhoGEF2 carried on the tip of a microtu- formed according to published methods [8, 25]. Templates for
in vitro transcription were generated by PCR with the primers encod-bule represents some quanta—a critical concentration
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ing the T7 promoter sequence upstream of the following: EB1 (5- Supplemental Data
Supplemental Figures and Movies are available with this articleGAGAATGGCTGTAAACGTCTACTCCACAAATGTG-3 and 5-GAG
ATGCCCGTGCTGTTGGCACAGGCGTTTA-3), Rho1 (5-ATCAAGA online at http://www.current-biology.com/cgi/content/full/14/20/
1827/DC1/.ACAACCAGAACATCG-3 and 5-TTTGTTTTGTGTTTAGTTCGGC-3),
DROK (5-GAGAACACTCAAAAGCTGAAAAAG-3 and 5-ACAGTTC
CTTCTGTAGCTGGTTTT-3), and DRhoGEF2 (5-ATGGATCACCCA Acknowledgments
TCAATCAAAAAACGG-3 and 5-TGTCCCGATCCCTATGACCACTA
AGGC-3). We are grateful to Liqun Luo for the gift of the pUAS-Rho1V14
Stable S2 cell lines expressing RLC-GFP were generated by co- construct, Roger Karess for the gift of the RLC-GFP construct, and
transfection with the expression construct and hygromycin resis- Eric Wieschaus for the gift of the Concertina constructs. We also
tance plasmid with the Cellfectin transfection reagent and then anti- thank Dyche Mullins for the use of his microscope and Greg Rogers
biotic selection as recommended by the manufacturer (Invitrogen, for artistic contributions.
Carlsbad, CA). Transient expression of UAS-Rho1V14 (gift of Liqun
Luo, Stanford University) was performed by cotransfection with Received: June 9, 2004
pMT-GAL4. Gene expression from constructs driven by the metal- Revised: August 31, 2004
lothionine promoter was induced by addition of 500 M copper Accepted: September 1, 2004
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